Answers are grounded in this paper and cite their sources.
Case report demonstrates successful cesarean delivery outcomes in a patient with acquired hemophilia A, indicating the viability of bypassing agents alone.
We report a confirmed case of pregnancy-associated acquired hemophilia A identified during preoperative evaluation for cesarean delivery. Although immunosuppressive therapy is generally recommended to eradicate factor VIII inhibitors, urgent delivery was required because of pregnancy-induced hypertension complicated by nephropathy. Under these circumstances, a cesarean delivery was performed without previous immunosuppressive treatment. Intraoperative hemostasis was well controlled, and both maternal and neonatal outcomes were favorable. This report may assist in clinical decision-making when invasive procedures are required in patients with acquired hemophilia A before therapeutic intervention with immunosuppressive therapy can be initiated.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: